Jump to Main Contents

Home > Divisions & Departments > Division of Medical Support and Partnership

Division of Medical Support and Partnership


Section Head

Pathology Consultation Section

Nobuyoshi Hiraoka

Cancer Screening Management Section

Hirokazu Takahashi


Rie Yamamoto, Yoshimasa Saito


Toshiyuki Minemura, Yoko Nakazawa, Ryoko Machii, Takashi Hanada, Emi Takeuchi, Risa Yamazaki, Kazuko Matsuda


Kaishi Satomi

Visiting Researcher

Hiroshi Saito, Hidenori Ojima, Miki Takahashi

Assisting Staff

Kiyomi Iino, Tokiko Iguchi, Mihoko Ueno, Hiroyo Ohchi, Mayumi Kobayashi, Ritsuko Chinda,
Hiromi Nakamura, Mamiko Maeshima, Mika Mizumoto, Yuri Yamauchi


The Division builds partnerships with Designated Cancer Care Hospitals to support all health-allied professionals concerned with cancer control in Japan. The Medical Support and Partnership Section (MSPS) plays a unique role in supporting Designated Cancer Care Hospitals in Japan. The Pathology Consultation Section (PCS) makes efforts to perform human pathology research based on the histology of tumor cells and tumor-stromal cells to improve diagnostic pathology of the tumors.  The Outreach Radiation Oncology and Physics Section (ORPS) provides the following support programs for designated regional cancer centers and institutions participating in clinical trials. The Cancer Control Education and Training Section (CCET) plays a central role in the planning, management and evaluation of specialized and multidisciplinary training programs for physicians and other health professionals as trainers of each designated cancer care hospital, to promote a comprehensive and systematic cancer control program in Japan.

Routine activities

Networking among Designated Cancer Care Hospitals

The MSPS held the Designated Cancer Care Hospitals Liaison-council and the Palliative Care Committee (a subsidiary organization) to enhance partnerships for cancer control, and the PDCA cycle Forum to improve the quality of cancer care in Japan. The designated cancer care hospitals are important partners with the National Cancer Center (NCC) to promote comprehensive cancer control in Japan.

Pathology consultation service

The PCS received 466 cases requesting a specialist's second opinion regarding histopathological diagnosis in 2015. There are 86 consultants registered, many of them highly recognized experts in specialty disciplines. One of them assigned as a consultant examines the slides and quickly sends back their opinion report to each client. Most of the clients expressed satisfaction with the contents of the report and this consultation system. We also selected typical or educational cases from accumulated archives and constructed a referential database.

Radiotherapy case service

Mailed dosimetry and on-site dosimetry were performed in 116 institutions and 17 institutions, respectively, at the ORPS. All data of the institutions were within the permissible limit.

Research activities

Develop a method to implement a PDCA cycle among the Designated Cancer Care Hospitals

The MSPS developed a method for carrying out a peer review about palliative care and examined how to implement the PDCA cycle continuously.

Develop the IMRT quality control support program

The ORPS were developing enforcement of the mailed dosimetry regarding the output dose of Intensity Modulated Radiotherapy (IMRT) in two institutions (designated regional cancer centers).

Clinical trials

The on-site dosimetry regarding the output dose of IMRT

In the Japan Clinical Oncology Group (JCOG1008, JCOG1208, JCOG1303) and the Japanese Radiation Oncology Study Group (JROSG12-1), the ORPS performed on-site dosimetry regarding the output dose of IMRT in 14 institutions.


The CCET provides and evaluates various oncology professional training programs about up-to-date information on early detection, diagnosis, treatment, nursing care, clinical trials and cancer statistics for physicians, nurses, pharmacists, cancer information (CI) specialists and cancer registrars. The CCET provides multidisciplinary training programs for Palliative Care Teams and Chemotherapy Teams. In order to develop leaders in each prefecture, CCET holds leadership training programs for skilled physicians, nurses, pharmacists and CI specialists. (Table 1, 2)

Future prospects

The MSPS searches a support system to meet the needs of the Designated Cancer Care hospitals. All sections will continue to be involved in our routine activities and education.

Table 1. Training programs conducted during April 2014 - March 2015

Table 2. Training programs conducted during April 2015 - March 2016

List of papers published in 2015


  1. Mori M, Shimizu C, Ogawa A, Okusaka T, Yoshida S, Morita T. A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions? Oncologist, 20時13分04-1311, 2015  [PubMed]